Back to Feed
总结
STAT等媒体回顾称，2026年JPM Week（摩根大通医疗健康大会周）已结束，本届会议总体氛围积极但更偏务实：与会者在密集路演与会谈中讨论生物医药融资、产品管线与估值预期，同时观察到“没有大并购”的局面，显示会议功能从交易撮合转向信息交换与预期校准。多家报道还聚焦医疗体系扩大临床场景的AI应用，生物科技的复苏热度也在市场与执行难题中接受检验。
正文
JPM Week 2026 is over. It was fantastic. Here's why statnews.com JPM 2026: How health systems are expanding clinical use of AI Modern Healthcare News All the meetings, none of the megadeals: Is JPM's purpose evolving? Fierce Biotech On biotech's biggest stage, renewed excitement gets a stress test BioPharma Dive 5 Takeaways From This Week's J.P. Morgan Healthcare Conference Forbes
发布时间：